AKLI

Akili, Inc. (AKLI) | Rumor.io

Akili

AKLI

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about AKLI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 16

Analysts have set a price target for AKLI (Akili, Inc.) for today.
New alerts have been posted in the last hours for AKLI.
Analysts have set a price target for AKLI (Akili, Inc.) for next week.

Generated by AI

Sentiment

Of the messages about AKLI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	20% new	0.39% -77.62
Bearish	—	—	80% -20	99.61% +77.62

Bullish· Apr 30

$AKLI has sold its Japanese rights for its ADHD product for approximately $20 million, leaving the company with a huge discount to its net cash value.
The company has a strong cash position with around $80 million in cash and has also rid itself of dead weight, maximizing shareholder value.
$AKLI has the potential to reach $1+ with significant buying pressure and a strong trend supported by elevated highs and lows, along with notable volume signaling increased buying interest.

Bearish· Feb 26

$AKLI is experiencing a weak bull-side, struggling to hold gains and vulnerable to profit-taking due to fear.
The stock has been dropping, with some investors already taking profits at $1.00 and others predicting it will soon be over $0.80.
$AKLI has been subject to significant price declines, with some investors taking significant losses, including one who took a 112% loss on their position.

Generated by AI

Topics

Of the messages about AKLI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	0%
Announcements	—	—	100%	99.45%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	0.55%

Announcements· May 29

Akili, Inc. ($AKLI) will be acquired by Virtual Therapeutics in a definitive merger agreement, with Akili shareholders receiving $0.4340 per share in cash.
The transaction represents a 4% premium to Akili's closing stock price on May 28 and an 85% premium to its closing price on April 29.
The combined organization will operate as Virtual Therapeutics, a privately held company, with Akili as a wholly owned subsidiary, and is expected to close in the third quarter of 2024.

Technical Analysis· Apr 30

$AKLI is showing signs of a stronger breakout at $0.385, with potential zones to be broken for further growth.
A cup and handle bull pattern is forming on $AKLI's chart, which could lead to a significant price increase.
$AKLI has broken over its VWAP (Volume-Weighted Average Price) and is trending upwards, with potential for further growth as long as it maintains a steady trend.

Generated by AI

Community

Of the messages about AKLI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	0%
Newcomers	—	—	100%	100%

Regulars· Apr 30

Akili, Inc. has announced an amended agreement with Shionogi, providing the company with near-term cash payments and the cancellation of a $5M debt obligation.
The complete float of Akili shares has been traded, with a traded volume of 29.9M shares, and the company's stock is trending with a 25.5% gain.
Akili's stock has been halted for news pending, and the company's VWAP has been crossed, with the stock currently holding above it, and a float rotation count of 1, indicating potential squeezing due to high volume compared to its shares float.

Newcomers· Apr 30

The company's ADHD product is being sold, with the Japanese rights being sold for approximately 20 million dollars.
There is a strong buying interest in the stock, with high volume already being traded, potentially setting up a nice stock for activism.
The stock needs to break through a resistance level of $0.40 to see a potential breakout, which could be a bullish sign for the stock.

Generated by AI

Also Discussed

Investors talking about AKLI also mention

#	Name	Attention
1	STBX - Starbox Group Holdings Ltd. Ordinary Shares	——
2	Jianzhi Education Technology Group Company Limited ADRJZ	0%+0
3	Magic Empire Global Ltd Class A Ordinary SharesMEGL	0%0
4	Shuttle Pharmaceuticals Holdings, Inc.SHPH	0%0
5	MGAM - Mobile Global Esports Inc.	——
6	Comera Life Sciences Holdings Inc.CMRA	0%0
7	Intelligent Living Application Group Inc.ILAG	0%new
8	DNAD - Social Capital Suvretta Holdings Corp. IV	——
9	APGN - Apexigen, Inc.	——
10	GRFX - Graphex Group Limited	——

Akili, Inc.

Location

Social

What share of all stock conversation is about AKLI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 16

Analysts have set a price target for AKLI (Akili, Inc.) for today.
New alerts have been posted in the last hours for AKLI.
Analysts have set a price target for AKLI (Akili, Inc.) for next week.

Generated by AI

Sentiment

Of the messages about AKLI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	20% new	0.39% -77.62
Bearish	—	—	80% -20	99.61% +77.62

Bullish· Apr 30

$AKLI has sold its Japanese rights for its ADHD product for approximately $20 million, leaving the company with a huge discount to its net cash value.
The company has a strong cash position with around $80 million in cash and has also rid itself of dead weight, maximizing shareholder value.
$AKLI has the potential to reach $1+ with significant buying pressure and a strong trend supported by elevated highs and lows, along with notable volume signaling increased buying interest.

Bearish· Feb 26

$AKLI is experiencing a weak bull-side, struggling to hold gains and vulnerable to profit-taking due to fear.
The stock has been dropping, with some investors already taking profits at $1.00 and others predicting it will soon be over $0.80.
$AKLI has been subject to significant price declines, with some investors taking significant losses, including one who took a 112% loss on their position.

Generated by AI

Topics

Of the messages about AKLI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	0%
Announcements	—	—	100%	99.45%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	0.55%

Announcements· May 29

Akili, Inc. ($AKLI) will be acquired by Virtual Therapeutics in a definitive merger agreement, with Akili shareholders receiving $0.4340 per share in cash.
The transaction represents a 4% premium to Akili's closing stock price on May 28 and an 85% premium to its closing price on April 29.
The combined organization will operate as Virtual Therapeutics, a privately held company, with Akili as a wholly owned subsidiary, and is expected to close in the third quarter of 2024.

Technical Analysis· Apr 30

$AKLI is showing signs of a stronger breakout at $0.385, with potential zones to be broken for further growth.
A cup and handle bull pattern is forming on $AKLI's chart, which could lead to a significant price increase.
$AKLI has broken over its VWAP (Volume-Weighted Average Price) and is trending upwards, with potential for further growth as long as it maintains a steady trend.

Generated by AI

Community

Of the messages about AKLI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	0%
Newcomers	—	—	100%	100%

Regulars· Apr 30

Akili, Inc. has announced an amended agreement with Shionogi, providing the company with near-term cash payments and the cancellation of a $5M debt obligation.
The complete float of Akili shares has been traded, with a traded volume of 29.9M shares, and the company's stock is trending with a 25.5% gain.
Akili's stock has been halted for news pending, and the company's VWAP has been crossed, with the stock currently holding above it, and a float rotation count of 1, indicating potential squeezing due to high volume compared to its shares float.

Newcomers· Apr 30

The company's ADHD product is being sold, with the Japanese rights being sold for approximately 20 million dollars.
There is a strong buying interest in the stock, with high volume already being traded, potentially setting up a nice stock for activism.
The stock needs to break through a resistance level of $0.40 to see a potential breakout, which could be a bullish sign for the stock.

Generated by AI

Akili

Social

Jun 16

Sentiment

Bullish· Apr 30

Bearish· Feb 26

Topics

Announcements· May 29

Technical Analysis· Apr 30

Community

Regulars· Apr 30

Newcomers· Apr 30

Also Discussed

Akili, Inc.

Company Information

Location

Social

Jun 16

Sentiment

Bullish· Apr 30

Bearish· Feb 26

Topics

Announcements· May 29

Technical Analysis· Apr 30

Community

Regulars· Apr 30

Newcomers· Apr 30

Also Discussed